Stock info AC Immune SA | Filter  Basic-Info

Stock: AC Immune SA (US broad)

Last Price 2.28 Max Price 3.78
Min Price 1.48 1 Year return -24.44
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USA

Sector Review AC Immune SA

Loading...
Year Turnover Total sector Market share
2019 102 136,070 0.08 %
2020 14 153,065 0.01 %
2021 0 227,669 0.00 %
2022 4 260,393 0.00 %
2023 16 215,054 0.01 %

Advice AC Immune SA

No Records Found



News AC Immune SA

No Records Found

Annual reports AC Immune SA

No Records Found

Profile AC Immune SA

No Records Found

Results AC Immune SA

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance AC Immune SA

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details AC Immune SA

Details
2016
2017
2018
2019
2020
Price
12.98
12.80
9.45
8.52
5.17
Eps
-0.13
-0.40
-0.73
0.59
-0.80
Price/earnings-ratio
-99.85
-32.00
-12.95
14.44
-2.55
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
2.34
1.74
2.34
3.49
2.77
Market to book
0.18
0.14
0.25
0.41
1.36
Cashflow per stock
-0.09
-0.33
-0.58
0.71
-0.77
Stocks
57
57
68
72
72
Market Cap
736.92
734.15
638.46
612.24
146.75

Dividend AC Immune SA

Price info AC Immune SA

Date
Price
08 Sep 2025
2.28
01 Sep 2025
2.04
21 Aug 2025
2.14
15 Aug 2025
2.13
08 Aug 2025
2.14
07 Aug 2025
2.08
06 Aug 2025
2.17
05 Aug 2025
2.45
04 Aug 2025
2.19
01 Aug 2025
2.12
31 Jul 2025
2.16
30 Jul 2025
2.18
29 Jul 2025
2.35
28 Jul 2025
2.37
25 Jul 2025
2.43
24 Jul 2025
2.43
23 Jul 2025
2.34
22 Jul 2025
2.31
21 Jul 2025
2.08
18 Jul 2025
2.07
17 Jul 2025
2.07
16 Jul 2025
2.06
15 Jul 2025
2.05
14 Jul 2025
2.08
11 Jul 2025
2.04
10 Jul 2025
2.11
09 Jul 2025
2.08
08 Jul 2025
2.07
07 Jul 2025
1.99
03 Jul 2025
2.07
Overig aandelennieuws
AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
Analist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2025 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo